Product standardisation as a tool to control prescribing costs - a case study of alginate liquid preparations.
Int J Pharm Pract
; 21(2): 73-81, 2013 Apr.
Article
de En
| MEDLINE
| ID: mdl-23418744
ABSTRACT
INTRODUCTION:
Product standardisation involves promoting the prescribing of pre-selected products within a particular category across a healthcare region and is designed to improve patient safety by promoting continuity of medicine use across the primary/secondary care interface, in addition to cost containment without compromising clinical care (i.e. maintaining safety and efficacy).OBJECTIVES:
To examine the impact of product standardisation on the prescribing of compound alginate preparations within primary care in Northern Ireland.METHODS:
Data were obtained on alginate prescribing from the Northern Ireland Central Services Agency (Prescription Pricing Branch), covering a period of 43 months. Two standardisation promotion interventions were carried out at months 18 and 33. In addition to conventional statistical analyses, a simple interrupted time series analysis approach, using graphical interpretation, was used to facilitate interpretation of the data.RESULTS:
There was a significant increase in the prescribed share of the preferred alginate product in each of the four health boards in Northern Ireland and a decrease in the cost per Defined Daily Dose for alginate liquid preparations overall. Compliance with the standardisation policy was, however, incomplete and was influenced to a marked degree by the activities of the pharmaceutical industry. The overall economic impact of the prescribing changes during the study was small (3.1%).CONCLUSION:
The findings suggested that product standardisation significantly influenced the prescribing pattern for compound alginate liquid preparations within primary care across Northern Ireland.
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Ordonnances médicamenteuses
/
Coûts des médicaments
/
Maîtrise des coûts
/
Alginates
/
Médicaments sur ordonnance
Type d'étude:
Health_economic_evaluation
Limites:
Humans
Pays/Région comme sujet:
Europa
Langue:
En
Journal:
Int J Pharm Pract
Sujet du journal:
FARMACIA
Année:
2013
Type de document:
Article
Pays d'affiliation:
Royaume-Uni